Northland Capital Markets Starts Electromed (ELMD) at Outperform

November 24, 2020 9:07 AM EST
Get Alerts ELMD Hot Sheet
Price: $11.74 +1.47%

Rating Summary:
    2 Buy, 0 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 18 | Down: 11 | New: 8
Trade Now! 
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.

Northland Capital Markets analyst James Terwilliger initiates coverage on Electromed (NYSE: ELMD) with a Outperform rating and a price target of $15.50.

The analyst commented, "We are initiating coverage of Electromed, Inc. (ELMD) with an Outperform rating and a twelve month price target of $15.00 or 30 times our current fiscal 2022 EPS estimate of $0.50. ELMD is a medical device company specializing in the manufacture and sale of medical devices for products that provide airway clearance therapy. Electromed provides therapy to patients with compromised pulmonary function through their SmartVest System with High Frequency Chest Wall Oscillation (HFCWO)."

For an analyst ratings summary and ratings history on Electromed click here. For more ratings news on Electromed click here.

Shares of Electromed closed at $9.79 yesterday.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst Comments, New Coverage